Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Transcenta gets US FDA clearance for launching phase 1 trial of TST005 Transcenta has secured clearance of its investigational new drug (IND) application for TST005 from the US Food and Drug… bySrinathApril 20, 2021
